Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here


Opinion: Rutgers President Robert Barchi Writes ‘Nation Must Honor the Promise of DACA — And the Bridge Act Is a Good Start’

Robert Barchi, M.D., Ph.D.

New Brunswick, NJ, September 11, 2017Rutgers University President Robert Barchi authored the following opinion piece that was published in The Philadelphia Inquirer on September 6:

Thousands of Rutgers University students have staged peaceful protests over the last year in anticipation of dramatic changes to immigration policy.

The Trump administration’s announcement Tuesday that it would end the Deferred Action for Childhood Arrivals (DACA) program unless Congress acts within the next six months wasn’t the dramatic change that we had all feared, but a six-month reprieve is only of minor comfort. Continue reading

Study: 46% of U.S. Innovators Are Immigrants or Children of Immigrants, Underscoring How Attracting the World’s Best and Brightest Contributes to U.S. Economic Growth


Washington, DC, February 13, 2017 The Information Technology and Innovation Foundation (ITIF), the leading U.S. science and tech policy think tank, on February 3 released the following statement from its president, Robert D. Atkinson, regarding President Trump’s expected executive order on the H-1B visa:

As President Trump continues to weigh possible reforms to the H-1B visa system, we urge him to consider the vital role that high-skilled immigrants play in the U.S. economy.

A 2016 ITIF study found that: Continue reading

Biotechnology Executives Write President, Arguing Immigration Ban Strikes at U.S. Medical Innovation and Patients

Washington, DC, February 9, 2017 — Carolyn Y. Johnson reports in The Washington Post that more than 160 leaders of biotechnology companies signed a strong letter of opposition to President Donald J. Trump’s travel ban, arguing the “poorly conceived and implemented” action strikes at the heart of an industry that originated in America, has been dominated by American companies and is at the cutting edge of medicine.

The letter, published Tuesday by the journal Nature Biotechnology, reveals that scientists abroad are afraid to come to the U.S. and are canceling trips.

Foreign-born scientists within the U.S. fear similar orders could be issued without warning, and some have expressed anxiety about deportation or losing family ties.  Ultimately, the letter argues, the policy will harm patients and the U.S. economy. Continue reading

Rutgers and Princeton Presidents Urge Trump to Drop the Immigration Ban

New Brunswick, NJ, February 4, 2017 — Adam Clark reports in The Star-Ledger that Rutgers President Robert Barchi and Princeton University President Chris Eisbruber joined more than 40 other college leaders Thursday in urging President Donald J. Trump to rescind his executive order banning immigration from seven majority-Muslim countries.

The college presidents wrote a letter to Trump telling him that his order threatens American higher education and the defining principles of the country. Continue reading